Remodelling of zero-stress state of small intestine in streptozotocin-induced diabetic rats. Effect of gliclazide

Digestive and Liver Disease

Volumn 34, Issue 10, 2002, Pages 707-716

  Zhao, J ^a   Sha, H ^b   Zhou, S ^b   Tong, X ^b   Zhuang, F Y ^b   Gregersen, H ^a  

^a AALBORG UNIVERSITY   (Denmark)

^b CHINA JAPAN FRIENDSHIP HOSPITAL   (China)

Author keywords

Diabetes; Gliclazide; Opening angle; Residual strain; Small intestine

Indexed keywords

GLICLAZIDE; GLUCOSE; INSULIN; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOMECHANICS; CALCULATION; CONTROLLED STUDY; DUODENUM; GLUCOSE BLOOD LEVEL; ILEUM; INSULIN BLOOD LEVEL; INTESTINE WALL; JEJUNUM; MALE; NONHUMAN; ORGAN WEIGHT; RAT; SMALL INTESTINE; STOMACH LAVAGE; STREPTOZOCIN DIABETES; STRESS; THICKNESS;

ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; GLICLAZIDE; HYPOGLYCEMIC AGENTS; INTESTINE, SMALL; MALE; RATS; RATS, WISTAR;

EID: 0036807204     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1590-8658(02)80022-6     Document Type: Article

References (29)

1. Folwaczny C, Riepl R, Tschop M, Landgraf R. Gastrointestinal involvement in patients with diabetes mellitus: Part I (first of two parts). Epidemiology, pathophysiology, clinical findings. Z Gastroenterol 1999;37:803-15.
2. Verne GN, Sninsky CA. Diabetes and the gastrointestinal tract. Gastroenterol Clin North Ann 1998;27:861-74.
3. Ziegler O, Drouin P. Hemobiological properties of gliclazide. J Diabetes Complications 1994;8:235-9.
4. Jennings PE. Vascular benefits of gliclazide beyond glycemic control. Metabolism 2000;49(Suppl 2):17-20.
5. Zoubi SA, Williams MD, Mayhew TM, Sparrow RA. Number and ultrastructure of epithelial cells in crypts and villi along the streptozotocin-diabetic small intestine: a quantitative study on the effects of insulin and aldose reductase inhibition. Virchows Arch 1995;427:187-93.
6. Mayhew TM, Carson FL, Sharma AK. Small intestinal morphology in experimental diabetic rats: a stereological study on the effects on an aldose reductase inhibitor (ponalrestat) given with or without conventional insulin therapy. Diabetologia 1989;32:649-54.
7. Zoubi SA, Mayhew TM, Sparrow RA. The small intestine in experimental diabetes: cellular adaptation in crypts and villi at different longitudinal sites. Virchows Arch 1995;426:501-7.
8. Tahara T, Yamamoto T. Morphological changes of the villous microvascular architecture and intestinal growth in rats with streptozotocin-induced diabetes. Virchows Arch A Pathol Anat Histopathol 1988;413:151-8.
9. Charlton M, Ahlman B, Nair KS. The effect of insulin on human small intestinal mucosal protein synthesis. Gastroenterology 2000;118:299-306.
10. Jørgensen CS, Ahrensberg JM, Gregersen H, Flyvberg A. Tension-strain relation and morphometry of rat small intestine in experimental diabetes. Dig Dis Sci 2001;46:960-7.
11. Gregersen H, Kassab GS, Fung YC. The zero-stress state of the gastrointestinal tract: biomechanical and functional implications. Dig Dis Sci 2000;45:2271-81.
12. da Tos V, Maran A, Vigili de Kreutzenberg S, Marchetto S, Tadiotto F, Bettio M, et al. Mechanism of acute and chronic hypoglycemic action of gliclazide. Acta Diabetol 2000;37:201-6.
13. Siegle ME, Ehrlein HJ. Effects of various agents on ileal post-prandial motor patterns and transit of chyme in dogs. Am J Physiol 1989;257:G698-703.
14. Gregersen H, Djurhuus JC. Impedance planimetry - a new approach to biomechanical intestinal wall properties. Dig Dis Sci 1991;9:332-40.
15. Gregersen H, Kassab G. Biomechanics of the gastrointestinal tract. Neurogastroenterol Mot 1996;8:277-97.
16. Storklholm JH, Villadsen GE, Jensen SL, Gregersen H. Passive elastic wall properties in isolated guinea pig small intestine. Dig Dis Sci 1995;40:976-82.
17. Gregersen H, Jørgensen CS, Dall FH, Jensen SL. Characteristics of spontaneous and evoked motility in the isolated perfused porcine duodenum. J Appl Physiol 1992;73:9-19.
18. Storklholm JH, Jørgensen CS, Dall FH, Jensen SL, Gregersen H. Differences exist in passive elastic wall properties between segments of isolated guinea-pig distal ileum and duodenum in vitro. Neurogastroenterol Mot 1994;6:21-7.
19. Gregersen H, Jørgensen CS, Dall FH. Biomechanical wall properties in the isolated perfused porcine duodenum: an experimental study using impedance planimetry. J Gastrointest Mot 1992;4:125-35.
20. Fung YC, editor. Biodynamics: circulation. New York: Springer-Verlag; 1984.
21. Vaishnav RN, Vossoughi J. Estimation of residual strain in aortic segments. In: Hall CW, editor. Biomedical engineering II: recent developments. New York: Pergamon; 1983. p. 330-3.
22. Omens JH, Vaplon SM, Fazeli B, McCulloch AD. Left ventricular geometric remodelling and residual stress in the rat heart. J Biomech Eng 1998;120:715-9.
23. Fung YC, Liu SQ. Change of zero-stress state of rat pulmonary arteries in hypoxic hypertension. J Appl Physiol 1992;262:2455-70.
24. Fung YC. What are the residual stresses doing in our blood vessels. Ann Biomed Eng 1991;19:237-49.
25. Zhao J, Lu X, Zhuang F, Gregersen H. Biomechanical and morphometric properties of the arterial wall referenced to the zero-stress state in experimental diabetes. Biorheology 2000;37:385-400.
26. Gabella G. Hypertrophy of intestinal smooth muscle. Cell Tissue Res 1979;201:277-88.
27. Bueno L, Fioramonti J, Ruckebusch Y. Rate of flow of digest and electrical activity of the small intestine in dogs and sheep. J Physiol 1975;292:16-26.
28. Gabella G. On the musculature of the gastro-intestinal tract of the guinea pig. Anat Embryol 1981;163:135-56.
29. Campbell DB, Lavielle R, Nathan C. The mode of action and clinical pharmacology of gliclazide: a review. Diabetes Res Clin Pract 1991;14(Suppl 2):S21-36.